David Mendelson

Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline

Systematic review or meta-analysis · Journal of Clinical Oncology · 2007 · 421 citations

Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer

Journal of Clinical Oncology · 2010 · Last of 13 authors · 390 citations